ID   ALDR_HUMAN              Reviewed;         316 AA.
AC   P15121; B2R8N3; Q5U031; Q6FGA4; Q6ICP2; Q9BS21; Q9UCI9;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   10-MAY-2017, entry version 200.
DE   RecName: Full=Aldose reductase;
DE            Short=AR;
DE            EC=1.1.1.21;
DE   AltName: Full=Aldehyde reductase;
DE   AltName: Full=Aldo-keto reductase family 1 member B1;
GN   Name=AKR1B1; Synonyms=ALDR1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PARTIAL PROTEIN SEQUENCE.
RX   PubMed=2498333;
RA   Bohren K.M., Bullock B., Wermuth B., Gabbay K.H.;
RT   "The aldo-keto reductase superfamily. cDNAs and deduced amino acid
RT   sequences of human aldehyde and aldose reductases.";
RL   J. Biol. Chem. 264:9547-9551(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Placenta;
RX   PubMed=2504709;
RA   Chung S., Lamendola J.;
RT   "Cloning and sequence determination of human placental aldose
RT   reductase gene.";
RL   J. Biol. Chem. 264:14775-14777(1989).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Fetus;
RX   PubMed=2510130; DOI=10.1093/nar/17.20.8368;
RA   Graham A., Hedge P.J., Powell S.J., Riley J., Brown L., Gammack A.,
RA   Carey F., Markham A.F.;
RT   "Nucleotide sequence of cDNA for human aldose reductase.";
RL   Nucleic Acids Res. 17:8368-8368(1989).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RC   TISSUE=Placenta;
RX   PubMed=2111143; DOI=10.1089/dna.1990.9.149;
RA   Grundmann U., Bohn H., Obermeier R., Amann E.;
RT   "Cloning and prokaryotic expression of a biologically active human
RT   placental aldose reductase.";
RL   DNA Cell Biol. 9:149-157(1990).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2112546;
RA   Nishimura C., Matsuura Y., Kokai Y., Akera T., Carper D., Morjana N.,
RA   Lyons C., Flynn T.G.;
RT   "Cloning and expression of human aldose reductase.";
RL   J. Biol. Chem. 265:9788-9792(1990).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=1901857;
RA   Graham A., Brown L., Hedge P.J., Gammack A.J., Markham A.F.;
RT   "Structure of the human aldose reductase gene.";
RL   J. Biol. Chem. 266:6872-6877(1991).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9195951; DOI=10.1074/jbc.272.26.16431;
RA   Ko B.C.B., Ruepp B., Bohren K.M., Gabbay K.H., Chung S.S.;
RT   "Identification and characterization of multiple osmotic response
RT   sequences in the human aldose reductase gene.";
RL   J. Biol. Chem. 272:16431-16437(1997).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Lymphoma;
RX   PubMed=14996095; DOI=10.1111/j.1365-2133.2004.05651.x;
RA   Hartmann T.B., Thiel D., Dummer R., Schadendorf D., Eichmueller S.;
RT   "SEREX identification of new tumour-associated antigens in cutaneous
RT   T-cell lymphoma.";
RL   Br. J. Dermatol. 150:252-258(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain cortex;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z.,
RA   Lu F., Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,
RA   Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,
RA   Rahman N., Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F.,
RA   Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,
RA   Bruns G.A.P., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,
RA   Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,
RA   Kim H.-G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,
RA   Winsor E.J.T., Grzeschik K.-H., Teebi A., Minassian B.A., Kere J.,
RA   Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,
RA   Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,
RA   Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W.,
RA   Mural R.J., Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [14]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, Eye, and Urinary bladder;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [15]
RP   PROTEIN SEQUENCE OF 131-162, AND TISSUE SPECIFICITY.
RX   PubMed=8435445; DOI=10.1016/0167-4889(93)90218-E;
RA   Ferraretto A., Negri A., Giuliani A., De Grada L., Fuhrman Conti A.M.,
RA   Ronchi S.;
RT   "Aldose reductase is involved in long-term adaptation of EUE cells to
RT   hyperosmotic stress.";
RL   Biochim. Biophys. Acta 1175:283-288(1993).
RN   [16]
RP   PROTEIN SEQUENCE OF 244-275.
RX   PubMed=2492527;
RA   Morjana N.A., Lyons C., Flynn T.G.;
RT   "Aldose reductase from human psoas muscle. Affinity labeling of an
RT   active site lysine by pyridoxal 5'-phosphate and pyridoxal 5'-
RT   diphospho-5'-adenosine.";
RL   J. Biol. Chem. 264:2912-2919(1989).
RN   [17]
RP   PROTEIN SEQUENCE OF 276-294, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain, and Cajal-Retzius cell;
RA   Lubec G., Vishwanath V.;
RL   Submitted (MAR-2007) to UniProtKB.
RN   [18]
RP   PROTEIN SEQUENCE OF 298-316, AND ENZYME REGULATION.
RX   PubMed=8343525; DOI=10.1016/0167-4838(93)90258-S;
RA   Liu S.Q., Bhatnagar A., Ansari N.H., Srivastava S.K.;
RT   "Identification of the reactive cysteine residue in human placenta
RT   aldose reductase.";
RL   Biochim. Biophys. Acta 1164:268-272(1993).
RN   [19]
RP   PARTIAL PROTEIN SEQUENCE, AND ACETYLATION AT ALA-2.
RC   TISSUE=Muscle;
RX   PubMed=8281941; DOI=10.1111/j.1432-1033.1993.tb18445.x;
RA   Jaquinod M., Potier N., Klarskov K., Reymann J.-M., Sorokine O.,
RA   Kieffer S., Barth P., Andriantomanga V., Biellmann J.-F.,
RA   van Dorsselaer A.;
RT   "Sequence of pig lens aldose reductase and electrospray mass
RT   spectrometry of non-covalent and covalent complexes.";
RL   Eur. J. Biochem. 218:893-903(1993).
RN   [20]
RP   MUTAGENESIS OF ASP-44; TYR-49; LYS-78 AND HIS-111.
RX   PubMed=8245005;
RA   Tarle I., Borhani D.W., Wilson D.K., Quiocho F.A., Petrash J.M.;
RT   "Probing the active site of human aldose reductase. Site-directed
RT   mutagenesis of Asp-43, Tyr-48, Lys-77, and His-110.";
RL   J. Biol. Chem. 268:25687-25693(1993).
RN   [21]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [22]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-95; LYS-222 AND LYS-263, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [23]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [24]
RP   X-RAY CRYSTALLOGRAPHY (1.65 ANGSTROMS).
RX   PubMed=1621098; DOI=10.1126/science.1621098;
RA   Wilson D.K., Bohren K.M., Gabbay K.H., Quiocho F.A.;
RT   "An unlikely sugar substrate site in the 1.65 A structure of the human
RT   aldose reductase holoenzyme implicated in diabetic complications.";
RL   Science 257:81-84(1992).
RN   [25]
RP   X-RAY CRYSTALLOGRAPHY (2.27 ANGSTROMS).
RX   PubMed=1447221;
RA   Borhani D.W., Harter T.M., Pertrash J.M.;
RT   "The crystal structure of the aldose reductase.NADPH binary complex.";
RL   J. Biol. Chem. 267:24841-24847(1992).
RN   [26]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS).
RX   PubMed=8234324; DOI=10.1073/pnas.90.21.9847;
RA   Wilson D.K., Tarle I., Petrash J.M., Quiocho F.A.;
RT   "Refined 1.8-A structure of human aldose reductase complexed with the
RT   potent inhibitor zopolrestat.";
RL   Proc. Natl. Acad. Sci. U.S.A. 90:9847-9851(1993).
RN   [27]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS).
RX   PubMed=9405046; DOI=10.1021/bi9717136;
RA   Harrison D.H., Bohren K.M., Petsko G.A., Ringe D., Gabbay K.H.;
RT   "The alrestatin double-decker: binding of two inhibitor molecules to
RT   human aldose reductase reveals a new specificity determinant.";
RL   Biochemistry 36:16134-16140(1997).
RN   [28]
RP   X-RAY CRYSTALLOGRAPHY (1.0 ANGSTROMS) IN COMPLEX WITH NADP AND
RP   SYNTHETIC INHIBITOR, AND ACTIVE SITE.
RX   PubMed=15272156; DOI=10.1107/S0907444904011370;
RA   Ruiz F., Hazemann I., Mitschler A., Joachimiak A., Schneider T.,
RA   Karplus M., Podjarny A.;
RT   "The crystallographic structure of the aldose reductase-IDD552 complex
RT   shows direct proton donation from tyrosine 48.";
RL   Acta Crystallogr. D 60:1347-1354(2004).
RN   [29]
RP   X-RAY CRYSTALLOGRAPHY (0.66 ANGSTROMS) IN COMPLEX WITH NADP AND
RP   SYNTHETIC INHIBITOR.
RX   PubMed=15146478; DOI=10.1002/prot.20015;
RA   Howard E.I., Sanishvili R., Cachau R.E., Mitschler A., Chevrier B.,
RA   Barth P., Lamour V., Van Zandt M., Sibley E., Bon C., Moras D.,
RA   Schneider T.R., Joachimiak A., Podjarny A.;
RT   "Ultrahigh resolution drug design I: details of interactions in human
RT   aldose reductase-inhibitor complex at 0.66 A.";
RL   Proteins 55:792-804(2004).
RN   [30]
RP   X-RAY CRYSTALLOGRAPHY (0.95 ANGSTROMS) IN COMPLEX WITH NADP AND
RP   SUBSTRATE ANALOG.
RX   PubMed=16337231; DOI=10.1016/j.jmb.2005.10.067;
RA   Steuber H., Zentgraf M., Podjarny A., Heine A., Klebe G.;
RT   "High-resolution crystal structure of aldose reductase complexed with
RT   the novel sulfonyl-pyridazinone inhibitor exhibiting an alternative
RT   active site anchoring group.";
RL   J. Mol. Biol. 356:45-56(2006).
RN   [31]
RP   X-RAY CRYSTALLOGRAPHY (0.82 ANGSTROMS) IN COMPLEX WITH NADP.
RX   PubMed=17505104; DOI=10.1107/S0907444907011997;
RA   Biadene M., Hazemann I., Cousido A., Ginell S., Joachimiak A.,
RA   Sheldrick G.M., Podjarny A., Schneider T.R.;
RT   "The atomic resolution structure of human aldose reductase reveals
RT   that rearrangement of a bound ligand allows the opening of the safety-
RT   belt loop.";
RL   Acta Crystallogr. D 63:665-672(2007).
RN   [32]
RP   X-RAY CRYSTALLOGRAPHY (1.55 ANGSTROMS) IN COMPLEX WITH NADP AND
RP   SYNTHETIC INHIBITOR.
RX   PubMed=17418233; DOI=10.1016/j.jmb.2007.03.021;
RA   Steuber H., Zentgraf M., La Motta C., Sartini S., Heine A., Klebe G.;
RT   "Evidence for a novel binding site conformer of aldose reductase in
RT   ligand-bound state.";
RL   J. Mol. Biol. 369:186-197(2007).
RN   [33]
RP   X-RAY CRYSTALLOGRAPHY (1.43 ANGSTROMS) IN COMPLEX WITH NADP AND
RP   SYNTHETIC INHIBITOR.
RX   PubMed=17368668; DOI=10.1016/j.jmb.2006.12.004;
RA   Steuber H., Heine A., Klebe G.;
RT   "Structural and thermodynamic study on aldose reductase: nitro-
RT   substituted inhibitors with strong enthalpic binding contribution.";
RL   J. Mol. Biol. 368:618-638(2007).
CC   -!- FUNCTION: Catalyzes the NADPH-dependent reduction of a wide
CC       variety of carbonyl-containing compounds to their corresponding
CC       alcohols with a broad range of catalytic efficiencies.
CC   -!- CATALYTIC ACTIVITY: Alditol + NAD(P)(+) = aldose + NAD(P)H.
CC   -!- ENZYME REGULATION: Cys-299 may regulate the kinetic and inhibition
CC       properties of the enzyme, but does not participate in catalysis.
CC       {ECO:0000269|PubMed:8343525}.
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:15146478,
CC       ECO:0000269|PubMed:15272156, ECO:0000269|PubMed:16337231,
CC       ECO:0000269|PubMed:17368668, ECO:0000269|PubMed:17418233,
CC       ECO:0000269|PubMed:17505104}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- TISSUE SPECIFICITY: Highly expressed in embryonic epithelial cells
CC       (EUE) in response to osmotic stress. {ECO:0000269|PubMed:8435445}.
CC   -!- SIMILARITY: Belongs to the aldo/keto reductase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; J04795; AAA51713.1; -; mRNA.
DR   EMBL; J05017; AAA51714.1; -; mRNA.
DR   EMBL; X15414; CAA33460.1; -; mRNA.
DR   EMBL; M34720; AAA35560.1; -; mRNA.
DR   EMBL; M34721; AAA35561.1; -; Genomic_DNA.
DR   EMBL; J05474; AAA51715.1; -; mRNA.
DR   EMBL; M59783; AAA51712.1; -; Genomic_DNA.
DR   EMBL; M59856; AAA51712.1; JOINED; Genomic_DNA.
DR   EMBL; AF032455; AAB88851.1; -; Genomic_DNA.
DR   EMBL; AF328729; AAN09721.1; -; mRNA.
DR   EMBL; AK313439; BAG36230.1; -; mRNA.
DR   EMBL; CR450351; CAG29347.1; -; mRNA.
DR   EMBL; CR542203; CAG47000.1; -; mRNA.
DR   EMBL; BT019859; AAV38662.1; -; mRNA.
DR   EMBL; CH236950; EAL24070.1; -; Genomic_DNA.
DR   EMBL; CH471070; EAW83814.1; -; Genomic_DNA.
DR   EMBL; BC000260; AAH00260.1; -; mRNA.
DR   EMBL; BC005387; AAH05387.1; -; mRNA.
DR   EMBL; BC010391; AAH10391.1; -; mRNA.
DR   CCDS; CCDS5831.1; -.
DR   PIR; A39763; A39763.
DR   RefSeq; NP_001619.1; NM_001628.3.
DR   UniGene; Hs.521212; -.
DR   PDB; 1ABN; X-ray; 2.40 A; A=2-316.
DR   PDB; 1ADS; X-ray; 1.65 A; A=2-316.
DR   PDB; 1AZ1; X-ray; 1.80 A; A=2-316.
DR   PDB; 1AZ2; X-ray; 2.90 A; A=2-316.
DR   PDB; 1EF3; X-ray; 2.80 A; A/B=2-316.
DR   PDB; 1EL3; X-ray; 1.70 A; A=1-316.
DR   PDB; 1IEI; X-ray; 2.50 A; A=1-316.
DR   PDB; 1MAR; X-ray; 1.80 A; A=2-316.
DR   PDB; 1PWL; X-ray; 1.10 A; A=1-316.
DR   PDB; 1PWM; X-ray; 0.92 A; A=1-316.
DR   PDB; 1T40; X-ray; 1.80 A; A=1-316.
DR   PDB; 1T41; X-ray; 1.05 A; A=1-316.
DR   PDB; 1US0; X-ray; 0.66 A; A=1-316.
DR   PDB; 1X96; X-ray; 1.40 A; A=1-316.
DR   PDB; 1X97; X-ray; 1.40 A; A=1-316.
DR   PDB; 1X98; X-ray; 1.30 A; A=1-316.
DR   PDB; 1XGD; X-ray; 2.10 A; A=2-316.
DR   PDB; 1Z3N; X-ray; 1.04 A; A=1-316.
DR   PDB; 1Z89; X-ray; 1.43 A; A=1-316.
DR   PDB; 1Z8A; X-ray; 0.95 A; A=1-316.
DR   PDB; 2ACQ; X-ray; 1.76 A; A=2-316.
DR   PDB; 2ACR; X-ray; 1.76 A; A=2-316.
DR   PDB; 2ACS; X-ray; 1.76 A; A=2-316.
DR   PDB; 2ACU; X-ray; 1.76 A; A=2-316.
DR   PDB; 2AGT; X-ray; 1.00 A; A=1-316.
DR   PDB; 2DUX; X-ray; 1.60 A; A=1-316.
DR   PDB; 2DUZ; X-ray; 1.60 A; A=1-316.
DR   PDB; 2DV0; X-ray; 1.62 A; A=1-316.
DR   PDB; 2F2K; X-ray; 1.94 A; A=1-316.
DR   PDB; 2FZ8; X-ray; 1.48 A; A=1-316.
DR   PDB; 2FZ9; X-ray; 1.60 A; A=1-316.
DR   PDB; 2FZB; X-ray; 1.50 A; A=6-316.
DR   PDB; 2FZD; X-ray; 1.08 A; A=6-316.
DR   PDB; 2HV5; X-ray; 1.59 A; A=1-316.
DR   PDB; 2HVN; X-ray; 1.58 A; A=1-316.
DR   PDB; 2HVO; X-ray; 1.65 A; A=1-316.
DR   PDB; 2I16; X-ray; 0.81 A; A=1-316.
DR   PDB; 2I17; X-ray; 0.81 A; A=1-316.
DR   PDB; 2IKG; X-ray; 1.43 A; A=1-316.
DR   PDB; 2IKH; X-ray; 1.55 A; A=1-316.
DR   PDB; 2IKI; X-ray; 1.47 A; A=1-316.
DR   PDB; 2IKJ; X-ray; 1.55 A; A=1-316.
DR   PDB; 2INE; X-ray; 1.90 A; A=2-316.
DR   PDB; 2INZ; X-ray; 1.95 A; A=2-316.
DR   PDB; 2IPW; X-ray; 2.00 A; A=2-316.
DR   PDB; 2IQ0; X-ray; 1.95 A; A=2-316.
DR   PDB; 2IQD; X-ray; 2.00 A; A=2-316.
DR   PDB; 2IS7; X-ray; 1.70 A; A=2-316.
DR   PDB; 2ISF; X-ray; 2.00 A; A=2-316.
DR   PDB; 2J8T; X-ray; 0.82 A; A=6-316.
DR   PDB; 2NVC; X-ray; 1.65 A; A=1-316.
DR   PDB; 2NVD; X-ray; 1.55 A; A=1-316.
DR   PDB; 2PD5; X-ray; 1.60 A; A=1-316.
DR   PDB; 2PD9; X-ray; 1.55 A; A=1-316.
DR   PDB; 2PDB; X-ray; 1.60 A; A=1-316.
DR   PDB; 2PDC; X-ray; 1.65 A; A=1-316.
DR   PDB; 2PDF; X-ray; 1.56 A; A=1-316.
DR   PDB; 2PDG; X-ray; 1.42 A; A=1-316.
DR   PDB; 2PDH; X-ray; 1.45 A; A=1-316.
DR   PDB; 2PDI; X-ray; 1.55 A; A=1-316.
DR   PDB; 2PDJ; X-ray; 1.57 A; A=1-316.
DR   PDB; 2PDK; X-ray; 1.55 A; A=1-316.
DR   PDB; 2PDL; X-ray; 1.47 A; A=1-316.
DR   PDB; 2PDM; X-ray; 1.75 A; A=1-316.
DR   PDB; 2PDN; X-ray; 1.70 A; A=1-316.
DR   PDB; 2PDP; X-ray; 1.65 A; A=1-316.
DR   PDB; 2PDQ; X-ray; 1.73 A; A=1-316.
DR   PDB; 2PDU; X-ray; 1.55 A; A=1-316.
DR   PDB; 2PDW; X-ray; 1.55 A; A=1-316.
DR   PDB; 2PDX; X-ray; 1.65 A; A=1-316.
DR   PDB; 2PDY; X-ray; 1.65 A; A=1-316.
DR   PDB; 2PEV; X-ray; 0.90 A; A=1-316.
DR   PDB; 2PF8; X-ray; 0.85 A; A=1-316.
DR   PDB; 2PFH; X-ray; 0.85 A; A=1-316.
DR   PDB; 2PZN; X-ray; 1.00 A; A=1-316.
DR   PDB; 2QXW; X-ray; 0.80 A; A=1-316.
DR   PDB; 2R24; X-ray; 1.75 A; A=1-316.
DR   PDB; 3BCJ; X-ray; 0.78 A; A=1-316.
DR   PDB; 3DN5; X-ray; 1.45 A; A=1-316.
DR   PDB; 3G5E; X-ray; 1.80 A; A=1-316.
DR   PDB; 3GHR; X-ray; 1.00 A; A=1-316.
DR   PDB; 3GHS; X-ray; 1.00 A; A=1-316.
DR   PDB; 3GHT; X-ray; 1.10 A; A=1-316.
DR   PDB; 3GHU; X-ray; 1.20 A; A=1-316.
DR   PDB; 3LBO; X-ray; 1.10 A; A=1-316.
DR   PDB; 3LD5; X-ray; 1.27 A; A=1-316.
DR   PDB; 3LEN; X-ray; 1.21 A; A=1-316.
DR   PDB; 3LEP; X-ray; 0.99 A; A=1-316.
DR   PDB; 3LQG; X-ray; 1.35 A; A=1-316.
DR   PDB; 3LQL; X-ray; 1.13 A; A=1-316.
DR   PDB; 3LZ3; X-ray; 1.03 A; A=1-316.
DR   PDB; 3LZ5; X-ray; 0.95 A; A=1-316.
DR   PDB; 3M0I; X-ray; 1.07 A; A=1-316.
DR   PDB; 3M4H; X-ray; 0.94 A; A=1-316.
DR   PDB; 3M64; X-ray; 1.30 A; A=1-316.
DR   PDB; 3MB9; X-ray; 1.65 A; A=1-316.
DR   PDB; 3MC5; X-ray; 1.14 A; A=1-316.
DR   PDB; 3ONB; X-ray; 1.45 A; A=2-316.
DR   PDB; 3ONC; X-ray; 1.06 A; A=2-316.
DR   PDB; 3P2V; X-ray; 1.69 A; A=1-316.
DR   PDB; 3Q65; X-ray; 2.09 A; A/B=1-316.
DR   PDB; 3Q67; X-ray; 1.55 A; A/B=1-316.
DR   PDB; 3RX2; X-ray; 1.90 A; A=1-316.
DR   PDB; 3RX3; X-ray; 1.90 A; A=1-316.
DR   PDB; 3RX4; X-ray; 2.00 A; A=1-316.
DR   PDB; 3S3G; X-ray; 1.80 A; A=1-316.
DR   PDB; 3T42; X-ray; 1.28 A; A=1-316.
DR   PDB; 3U2C; X-ray; 1.00 A; A=1-316.
DR   PDB; 3V35; X-ray; 1.90 A; A=1-316.
DR   PDB; 3V36; X-ray; 2.00 A; A=1-316.
DR   PDB; 4GCA; X-ray; 0.90 A; A=2-316.
DR   PDB; 4GQ0; X-ray; 2.10 A; A=1-316.
DR   PDB; 4IGS; X-ray; 0.85 A; A=1-316.
DR   PDB; 4JIR; X-ray; 2.00 A; A=1-316.
DR   PDB; 4LAU; X-ray; 0.84 A; A=1-316.
DR   PDB; 4LAZ; X-ray; 0.85 A; A=1-316.
DR   PDB; 4LB3; X-ray; 0.80 A; A=1-316.
DR   PDB; 4LB4; X-ray; 0.80 A; A=1-316.
DR   PDB; 4LBR; X-ray; 0.80 A; A=1-316.
DR   PDB; 4LBS; X-ray; 0.76 A; A=1-316.
DR   PDB; 4NKC; X-ray; 1.12 A; A=2-316.
DR   PDB; 4PR4; X-ray; 1.06 A; A=2-316.
DR   PDB; 4PRR; X-ray; 1.01 A; A=2-316.
DR   PDB; 4PRT; X-ray; 0.96 A; A=1-316.
DR   PDB; 4PUU; X-ray; 1.14 A; A=1-316.
DR   PDB; 4PUW; X-ray; 1.12 A; A=1-316.
DR   PDB; 4Q7B; X-ray; 1.19 A; A=2-316.
DR   PDB; 4QBX; X-ray; 0.98 A; A=1-316.
DR   PDB; 4QR6; X-ray; 1.05 A; A=1-316.
DR   PDB; 4QX4; X-ray; 1.26 A; A=1-316.
DR   PDB; 4QXI; X-ray; 0.87 A; A=1-316.
DR   PDB; 4RPQ; X-ray; 1.20 A; A=2-316.
DR   PDB; 4XZH; X-ray; 1.00 A; A/B=1-316.
DR   PDB; 4XZI; X-ray; 2.45 A; A=1-316.
DR   PDB; 4YS1; X-ray; 1.07 A; A=1-316.
DR   PDB; 4YU1; X-ray; 1.02 A; A=1-316.
DR   PDB; 5HA7; X-ray; 1.65 A; A/B=1-316.
DR   PDBsum; 1ABN; -.
DR   PDBsum; 1ADS; -.
DR   PDBsum; 1AZ1; -.
DR   PDBsum; 1AZ2; -.
DR   PDBsum; 1EF3; -.
DR   PDBsum; 1EL3; -.
DR   PDBsum; 1IEI; -.
DR   PDBsum; 1MAR; -.
DR   PDBsum; 1PWL; -.
DR   PDBsum; 1PWM; -.
DR   PDBsum; 1T40; -.
DR   PDBsum; 1T41; -.
DR   PDBsum; 1US0; -.
DR   PDBsum; 1X96; -.
DR   PDBsum; 1X97; -.
DR   PDBsum; 1X98; -.
DR   PDBsum; 1XGD; -.
DR   PDBsum; 1Z3N; -.
DR   PDBsum; 1Z89; -.
DR   PDBsum; 1Z8A; -.
DR   PDBsum; 2ACQ; -.
DR   PDBsum; 2ACR; -.
DR   PDBsum; 2ACS; -.
DR   PDBsum; 2ACU; -.
DR   PDBsum; 2AGT; -.
DR   PDBsum; 2DUX; -.
DR   PDBsum; 2DUZ; -.
DR   PDBsum; 2DV0; -.
DR   PDBsum; 2F2K; -.
DR   PDBsum; 2FZ8; -.
DR   PDBsum; 2FZ9; -.
DR   PDBsum; 2FZB; -.
DR   PDBsum; 2FZD; -.
DR   PDBsum; 2HV5; -.
DR   PDBsum; 2HVN; -.
DR   PDBsum; 2HVO; -.
DR   PDBsum; 2I16; -.
DR   PDBsum; 2I17; -.
DR   PDBsum; 2IKG; -.
DR   PDBsum; 2IKH; -.
DR   PDBsum; 2IKI; -.
DR   PDBsum; 2IKJ; -.
DR   PDBsum; 2INE; -.
DR   PDBsum; 2INZ; -.
DR   PDBsum; 2IPW; -.
DR   PDBsum; 2IQ0; -.
DR   PDBsum; 2IQD; -.
DR   PDBsum; 2IS7; -.
DR   PDBsum; 2ISF; -.
DR   PDBsum; 2J8T; -.
DR   PDBsum; 2NVC; -.
DR   PDBsum; 2NVD; -.
DR   PDBsum; 2PD5; -.
DR   PDBsum; 2PD9; -.
DR   PDBsum; 2PDB; -.
DR   PDBsum; 2PDC; -.
DR   PDBsum; 2PDF; -.
DR   PDBsum; 2PDG; -.
DR   PDBsum; 2PDH; -.
DR   PDBsum; 2PDI; -.
DR   PDBsum; 2PDJ; -.
DR   PDBsum; 2PDK; -.
DR   PDBsum; 2PDL; -.
DR   PDBsum; 2PDM; -.
DR   PDBsum; 2PDN; -.
DR   PDBsum; 2PDP; -.
DR   PDBsum; 2PDQ; -.
DR   PDBsum; 2PDU; -.
DR   PDBsum; 2PDW; -.
DR   PDBsum; 2PDX; -.
DR   PDBsum; 2PDY; -.
DR   PDBsum; 2PEV; -.
DR   PDBsum; 2PF8; -.
DR   PDBsum; 2PFH; -.
DR   PDBsum; 2PZN; -.
DR   PDBsum; 2QXW; -.
DR   PDBsum; 2R24; -.
DR   PDBsum; 3BCJ; -.
DR   PDBsum; 3DN5; -.
DR   PDBsum; 3G5E; -.
DR   PDBsum; 3GHR; -.
DR   PDBsum; 3GHS; -.
DR   PDBsum; 3GHT; -.
DR   PDBsum; 3GHU; -.
DR   PDBsum; 3LBO; -.
DR   PDBsum; 3LD5; -.
DR   PDBsum; 3LEN; -.
DR   PDBsum; 3LEP; -.
DR   PDBsum; 3LQG; -.
DR   PDBsum; 3LQL; -.
DR   PDBsum; 3LZ3; -.
DR   PDBsum; 3LZ5; -.
DR   PDBsum; 3M0I; -.
DR   PDBsum; 3M4H; -.
DR   PDBsum; 3M64; -.
DR   PDBsum; 3MB9; -.
DR   PDBsum; 3MC5; -.
DR   PDBsum; 3ONB; -.
DR   PDBsum; 3ONC; -.
DR   PDBsum; 3P2V; -.
DR   PDBsum; 3Q65; -.
DR   PDBsum; 3Q67; -.
DR   PDBsum; 3RX2; -.
DR   PDBsum; 3RX3; -.
DR   PDBsum; 3RX4; -.
DR   PDBsum; 3S3G; -.
DR   PDBsum; 3T42; -.
DR   PDBsum; 3U2C; -.
DR   PDBsum; 3V35; -.
DR   PDBsum; 3V36; -.
DR   PDBsum; 4GCA; -.
DR   PDBsum; 4GQ0; -.
DR   PDBsum; 4IGS; -.
DR   PDBsum; 4JIR; -.
DR   PDBsum; 4LAU; -.
DR   PDBsum; 4LAZ; -.
DR   PDBsum; 4LB3; -.
DR   PDBsum; 4LB4; -.
DR   PDBsum; 4LBR; -.
DR   PDBsum; 4LBS; -.
DR   PDBsum; 4NKC; -.
DR   PDBsum; 4PR4; -.
DR   PDBsum; 4PRR; -.
DR   PDBsum; 4PRT; -.
DR   PDBsum; 4PUU; -.
DR   PDBsum; 4PUW; -.
DR   PDBsum; 4Q7B; -.
DR   PDBsum; 4QBX; -.
DR   PDBsum; 4QR6; -.
DR   PDBsum; 4QX4; -.
DR   PDBsum; 4QXI; -.
DR   PDBsum; 4RPQ; -.
DR   PDBsum; 4XZH; -.
DR   PDBsum; 4XZI; -.
DR   PDBsum; 4YS1; -.
DR   PDBsum; 4YU1; -.
DR   PDBsum; 5HA7; -.
DR   ProteinModelPortal; P15121; -.
DR   SMR; P15121; -.
DR   BioGrid; 106732; 43.
DR   IntAct; P15121; 2.
DR   MINT; MINT-1196717; -.
DR   STRING; 9606.ENSP00000285930; -.
DR   BindingDB; P15121; -.
DR   ChEMBL; CHEMBL1900; -.
DR   DrugBank; DB07028; (2-{[(4-BROMO-2-FLUOROBENZYL)AMINO]CARBONYL}-5-CHLOROPHENOXY)ACETIC ACID.
DR   DrugBank; DB07030; (5-CHLORO-2-{[(3-NITROBENZYL)AMINO]CARBONYL}PHENOXY)ACETIC ACID.
DR   DrugBank; DB03461; 2'-Monophosphoadenosine 5'-Diphosphoribose.
DR   DrugBank; DB07139; 3-[5-(3-nitrophenyl)thiophen-2-yl]propanoic acid.
DR   DrugBank; DB07187; 6-[(5-CHLORO-3-METHYL-1-BENZOFURAN-2-YL)SULFONYL]PYRIDAZIN-3(2H)-ONE.
DR   DrugBank; DB02007; alpha-D-glucose 6-phosphate.
DR   DrugBank; DB02020; Alrestatin.
DR   DrugBank; DB05327; AS-3201.
DR   DrugBank; DB04272; Citric Acid.
DR   DrugBank; DB02021; Fidarestat.
DR   DrugBank; DB02994; Hydroxydimethylarsine Oxide.
DR   DrugBank; DB02834; IDD552.
DR   DrugBank; DB08084; IDD594.
DR   DrugBank; DB01689; Inhibitor Idd 384.
DR   DrugBank; DB02518; N-Acetylalanine.
DR   DrugBank; DB00157; NADH.
DR   DrugBank; DB05383; pimagedine HCl.
DR   DrugBank; DB02712; Sorbinil.
DR   DrugBank; DB00605; Sulindac.
DR   DrugBank; DB02383; Tolrestat.
DR   GuidetoPHARMACOLOGY; 2768; -.
DR   SwissLipids; SLP:000001112; -.
DR   iPTMnet; P15121; -.
DR   PhosphoSitePlus; P15121; -.
DR   SwissPalm; P15121; -.
DR   BioMuta; AKR1B1; -.
DR   DMDM; 113596; -.
DR   DOSAC-COBS-2DPAGE; P15121; -.
DR   REPRODUCTION-2DPAGE; IPI00413641; -.
DR   REPRODUCTION-2DPAGE; P15121; -.
DR   UCD-2DPAGE; P15121; -.
DR   EPD; P15121; -.
DR   MaxQB; P15121; -.
DR   PaxDb; P15121; -.
DR   PeptideAtlas; P15121; -.
DR   PRIDE; P15121; -.
DR   TopDownProteomics; P15121; -.
DR   DNASU; 231; -.
DR   Ensembl; ENST00000285930; ENSP00000285930; ENSG00000085662.
DR   GeneID; 231; -.
DR   KEGG; hsa:231; -.
DR   UCSC; uc003vrp.2; human.
DR   CTD; 231; -.
DR   DisGeNET; 231; -.
DR   GeneCards; AKR1B1; -.
DR   HGNC; HGNC:381; AKR1B1.
DR   HPA; CAB027391; -.
DR   HPA; CAB047353; -.
DR   HPA; HPA026425; -.
DR   HPA; HPA052751; -.
DR   MIM; 103880; gene.
DR   neXtProt; NX_P15121; -.
DR   OpenTargets; ENSG00000085662; -.
DR   PharmGKB; PA24675; -.
DR   eggNOG; KOG1577; Eukaryota.
DR   eggNOG; COG0656; LUCA.
DR   GeneTree; ENSGT00760000119041; -.
DR   HOVERGEN; HBG000020; -.
DR   InParanoid; P15121; -.
DR   KO; K00011; -.
DR   OMA; CALMSCA; -.
DR   OrthoDB; EOG091G0D69; -.
DR   PhylomeDB; P15121; -.
DR   TreeFam; TF106492; -.
DR   BioCyc; MetaCyc:HS01502-MONOMER; -.
DR   BRENDA; 1.1.1.188; 2681.
DR   BRENDA; 1.1.1.21; 2681.
DR   Reactome; R-HSA-196108; Pregnenolone biosynthesis.
DR   Reactome; R-HSA-5652227; Fructose biosynthesis.
DR   SABIO-RK; P15121; -.
DR   ChiTaRS; AKR1B1; human.
DR   EvolutionaryTrace; P15121; -.
DR   GeneWiki; AKR1B1; -.
DR   GenomeRNAi; 231; -.
DR   PRO; PR:P15121; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000085662; -.
DR   CleanEx; HS_AKR1B1; -.
DR   ExpressionAtlas; P15121; baseline and differential.
DR   Genevisible; P15121; HS.
DR   GO; GO:0032838; C:cell projection cytoplasm; IEA:Ensembl.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; TAS:ProtInc.
DR   GO; GO:0042629; C:mast cell granule; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0033010; C:paranodal junction; IEA:Ensembl.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl.
DR   GO; GO:0043220; C:Schmidt-Lanterman incisure; IEA:Ensembl.
DR   GO; GO:0097454; C:Schwann cell microvillus; IEA:Ensembl.
DR   GO; GO:0004032; F:alditol:NADP+ 1-oxidoreductase activity; EXP:Reactome.
DR   GO; GO:0004033; F:aldo-keto reductase (NADP) activity; TAS:UniProtKB.
DR   GO; GO:0009055; F:electron carrier activity; TAS:UniProtKB.
DR   GO; GO:0043795; F:glyceraldehyde oxidoreductase activity; IDA:UniProtKB.
DR   GO; GO:0006700; P:C21-steroid hormone biosynthetic process; TAS:Reactome.
DR   GO; GO:0005975; P:carbohydrate metabolic process; TAS:ProtInc.
DR   GO; GO:0070301; P:cellular response to hydrogen peroxide; IEA:Ensembl.
DR   GO; GO:0097238; P:cellular response to methylglyoxal; IEA:Ensembl.
DR   GO; GO:1901653; P:cellular response to peptide; IEA:Ensembl.
DR   GO; GO:0044597; P:daunorubicin metabolic process; IMP:UniProtKB.
DR   GO; GO:0044598; P:doxorubicin metabolic process; IMP:UniProtKB.
DR   GO; GO:0046370; P:fructose biosynthetic process; TAS:Reactome.
DR   GO; GO:0072061; P:inner medullary collecting duct development; IEA:Ensembl.
DR   GO; GO:0060135; P:maternal process involved in female pregnancy; IEA:Ensembl.
DR   GO; GO:0018931; P:naphthalene metabolic process; IEA:Ensembl.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl.
DR   GO; GO:0042415; P:norepinephrine metabolic process; IEA:Ensembl.
DR   GO; GO:0046427; P:positive regulation of JAK-STAT cascade; IEA:Ensembl.
DR   GO; GO:0048661; P:positive regulation of smooth muscle cell proliferation; IEA:Ensembl.
DR   GO; GO:0035809; P:regulation of urine volume; IEA:Ensembl.
DR   GO; GO:0003091; P:renal water homeostasis; IEA:Ensembl.
DR   GO; GO:0006950; P:response to stress; TAS:UniProtKB.
DR   GO; GO:0097066; P:response to thyroid hormone; IEA:Ensembl.
DR   GO; GO:0009414; P:response to water deprivation; IEA:Ensembl.
DR   GO; GO:0006061; P:sorbitol biosynthetic process; IEA:Ensembl.
DR   GO; GO:0031098; P:stress-activated protein kinase signaling cascade; IEA:Ensembl.
DR   GO; GO:0001894; P:tissue homeostasis; IEA:Ensembl.
DR   CDD; cd06660; Aldo_ket_red; 1.
DR   Gene3D; 3.20.20.100; -; 1.
DR   InterPro; IPR018170; Aldo/ket_reductase_CS.
DR   InterPro; IPR020471; Aldo/keto_reductase.
DR   InterPro; IPR023210; NADP_OxRdtase_dom.
DR   PANTHER; PTHR11732; PTHR11732; 1.
DR   Pfam; PF00248; Aldo_ket_red; 1.
DR   PIRSF; PIRSF000097; AKR; 1.
DR   PRINTS; PR00069; ALDKETRDTASE.
DR   SUPFAM; SSF51430; SSF51430; 1.
DR   PROSITE; PS00798; ALDOKETO_REDUCTASE_1; 1.
DR   PROSITE; PS00062; ALDOKETO_REDUCTASE_2; 1.
DR   PROSITE; PS00063; ALDOKETO_REDUCTASE_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; NADP; Oxidoreductase; Phosphoprotein;
KW   Polymorphism; Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330,
FT                                ECO:0000269|PubMed:8281941}.
FT   CHAIN         2    316       Aldose reductase.
FT                                /FTId=PRO_0000124623.
FT   NP_BIND      10     19       NADP. {ECO:0000255}.
FT   NP_BIND     211    273       NADP. {ECO:0000269|PubMed:15146478,
FT                                ECO:0000269|PubMed:15272156,
FT                                ECO:0000269|PubMed:16337231,
FT                                ECO:0000269|PubMed:17368668,
FT                                ECO:0000269|PubMed:17418233,
FT                                ECO:0000269|PubMed:17505104}.
FT   ACT_SITE     49     49       Proton donor.
FT                                {ECO:0000269|PubMed:15272156}.
FT   BINDING     111    111       Substrate.
FT   SITE         78     78       Lowers pKa of active site Tyr.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000269|PubMed:8281941}.
FT   MOD_RES       3      3       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P07943}.
FT   MOD_RES      95     95       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     222    222       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     263    263       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   VARIANT      15     15       I -> F (in dbSNP:rs5054).
FT                                /FTId=VAR_014743.
FT   VARIANT      42     42       H -> L (in dbSNP:rs5056).
FT                                /FTId=VAR_014744.
FT   VARIANT      73     73       L -> V (in dbSNP:rs5057).
FT                                /FTId=VAR_014745.
FT   VARIANT      90     90       K -> E (in dbSNP:rs2229542).
FT                                /FTId=VAR_048213.
FT   VARIANT     204    204       G -> S (in dbSNP:rs5061).
FT                                /FTId=VAR_014746.
FT   VARIANT     288    288       T -> I (in dbSNP:rs5062).
FT                                /FTId=VAR_014747.
FT   MUTAGEN      44     44       D->N: Reduced enzymatic activity.
FT                                {ECO:0000269|PubMed:8245005}.
FT   MUTAGEN      49     49       Y->F: Complete loss of enzymatic
FT                                activity. {ECO:0000269|PubMed:8245005}.
FT   MUTAGEN      78     78       K->M: Reduced enzymatic activity.
FT                                {ECO:0000269|PubMed:8245005}.
FT   MUTAGEN     111    111       H->N: Reduced enzymatic activity.
FT                                {ECO:0000269|PubMed:8245005}.
FT   CONFLICT      5      5       L -> I (in Ref. 2; AAA51714).
FT                                {ECO:0000305}.
FT   CONFLICT    114    114       T -> I (in Ref. 10; CAG47000).
FT                                {ECO:0000305}.
FT   CONFLICT    117    117       K -> R (in Ref. 10; CAG29347).
FT                                {ECO:0000305}.
FT   CONFLICT    142    142       W -> R (in Ref. 14; AAH05387).
FT                                {ECO:0000305}.
FT   CONFLICT    172    172       N -> S (in Ref. 10; CAG29347).
FT                                {ECO:0000305}.
FT   CONFLICT    270    272       IAE -> EAA (in Ref. 16; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    307    307       H -> M (in Ref. 18; AA sequence).
FT                                {ECO:0000305}.
FT   STRAND        3      6       {ECO:0000244|PDB:1US0}.
FT   STRAND       12     16       {ECO:0000244|PDB:1US0}.
FT   HELIX        25     38       {ECO:0000244|PDB:1US0}.
FT   STRAND       42     44       {ECO:0000244|PDB:1US0}.
FT   HELIX        47     49       {ECO:0000244|PDB:1US0}.
FT   HELIX        52     64       {ECO:0000244|PDB:1US0}.
FT   HELIX        70     72       {ECO:0000244|PDB:1US0}.
FT   STRAND       74     79       {ECO:0000244|PDB:1US0}.
FT   HELIX        81     83       {ECO:0000244|PDB:1US0}.
FT   TURN         86     88       {ECO:0000244|PDB:1US0}.
FT   HELIX        89    100       {ECO:0000244|PDB:1US0}.
FT   STRAND      105    113       {ECO:0000244|PDB:1US0}.
FT   STRAND      118    120       {ECO:0000244|PDB:2PDC}.
FT   STRAND      127    129       {ECO:0000244|PDB:3U2C}.
FT   HELIX       138    150       {ECO:0000244|PDB:1US0}.
FT   STRAND      153    155       {ECO:0000244|PDB:1US0}.
FT   STRAND      157    161       {ECO:0000244|PDB:1US0}.
FT   HELIX       164    171       {ECO:0000244|PDB:1US0}.
FT   STRAND      181    186       {ECO:0000244|PDB:1US0}.
FT   HELIX       194    202       {ECO:0000244|PDB:1US0}.
FT   STRAND      206    211       {ECO:0000244|PDB:1US0}.
FT   STRAND      223    225       {ECO:0000244|PDB:2ACQ}.
FT   TURN        228    230       {ECO:0000244|PDB:1US0}.
FT   HELIX       232    241       {ECO:0000244|PDB:1US0}.
FT   HELIX       245    255       {ECO:0000244|PDB:1US0}.
FT   STRAND      259    261       {ECO:0000244|PDB:1XGD}.
FT   HELIX       267    274       {ECO:0000244|PDB:1US0}.
FT   HELIX       283    290       {ECO:0000244|PDB:1US0}.
FT   HELIX       302    304       {ECO:0000244|PDB:1US0}.
FT   STRAND      307    309       {ECO:0000244|PDB:1IEI}.
FT   STRAND      311    314       {ECO:0000244|PDB:3U2C}.
SQ   SEQUENCE   316 AA;  35853 MW;  1852E8616B5DCEAE CRC64;
     MASRLLLNNG AKMPILGLGT WKSPPGQVTE AVKVAIDVGY RHIDCAHVYQ NENEVGVAIQ
     EKLREQVVKR EELFIVSKLW CTYHEKGLVK GACQKTLSDL KLDYLDLYLI HWPTGFKPGK
     EFFPLDESGN VVPSDTNILD TWAAMEELVD EGLVKAIGIS NFNHLQVEMI LNKPGLKYKP
     AVNQIECHPY LTQEKLIQYC QSKGIVVTAY SPLGSPDRPW AKPEDPSLLE DPRIKAIAAK
     HNKTTAQVLI RFPMQRNLVV IPKSVTPERI AENFKVFDFE LSSQDMTTLL SYNRNWRVCA
     LLSCTSHKDY PFHEEF
//
